These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


150 related items for PubMed ID: 6187120

  • 1. Immunohistochemical analysis of thyroglobulin and keratin in benign and malignant thyroid tumours.
    Permanetter W, Nathrath WB, Löhrs U.
    Virchows Arch A Pathol Anat Histopathol; 1982; 398(2):221-8. PubMed ID: 6187120
    [Abstract] [Full Text] [Related]

  • 2. Expression of keratin 19 distinguishes papillary thyroid carcinoma from follicular carcinomas and follicular thyroid adenoma.
    Schelfhout LJ, Van Muijen GN, Fleuren GJ.
    Am J Clin Pathol; 1989 Nov; 92(5):654-8. PubMed ID: 2479256
    [Abstract] [Full Text] [Related]

  • 3. [Immunohistochemical detection of thyroglobulin].
    Sturm U, Grossmann H, Schuh D, Zotter S, Müller M.
    Zentralbl Allg Pathol; 1989 Nov; 135(3):281-5. PubMed ID: 2672678
    [Abstract] [Full Text] [Related]

  • 4. Immunohistochemical demonstration of thyroglobulin in thyroid pathology.
    Stefăneanu L, Simionescu L, Aman E, Taşcă C.
    Endocrinologie; 1984 Nov; 22(1):55-9. PubMed ID: 6369503
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Value of immunoperoxidase staining of thyroglobulin in fine needle aspiration cytology of thyroid diseases.
    Tung CC, Chang TC, Hsieh HC.
    Acta Cytol; 1995 Nov; 39(3):396-401. PubMed ID: 7539201
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The localization of cytoskeletal proteins and thyroglobulin in thyroid microcarcinoma in comparison with clinically manifested thyroid carcinoma.
    Yagi Y, Yagi S, Saku T.
    Cancer; 1985 Oct 15; 56(8):1967-71. PubMed ID: 2411384
    [Abstract] [Full Text] [Related]

  • 12. Immunohistochemistry of thyroid hormones as a functional parameter in thyroid pathology.
    Taşcă C, Stefăneanu L, Simionescu L, Medeşan C.
    Morphol Embryol (Bucur); 1985 Oct 15; 31(4):261-8. PubMed ID: 2934622
    [Abstract] [Full Text] [Related]

  • 13. [Impact of serum thyroglobulin concentration in the diagnosis of benign and malignant thyroid diseases].
    Rink T, Dembowski W, Schroth HJ, Klinger K.
    Nuklearmedizin; 2000 Aug 15; 39(5):133-8. PubMed ID: 10984889
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Immunoradiometric assay for human thyroglobulin and variations in thyroid pathology.
    Eber M, Abecassis J, Grob JC, Ott G, Methlin G.
    Clin Chim Acta; 1980 Jul 17; 105(1):51-8. PubMed ID: 6893171
    [Abstract] [Full Text] [Related]

  • 16. Thyroglobulin in carcinoma of the thyroid: an immunohistochemical study.
    Albores-Saavedra J, Nadji M, Civantos F, Morales AR.
    Hum Pathol; 1983 Jan 17; 14(1):62-6. PubMed ID: 6832751
    [Abstract] [Full Text] [Related]

  • 17. [Thyroglobulin immunohistochemistry: new aspects of pathophysiology and differential diagnosis of benign and malignant goitre (author's transl)].
    Dralle H, Böcker W.
    Langenbecks Arch Chir; 1982 Jan 17; 356(3):205-12. PubMed ID: 7070163
    [Abstract] [Full Text] [Related]

  • 18. Immunohistochemical studies on thyroid peroxidase and thyroglobulin in 13 human thyroid tumors and 7 Graves' goiters.
    Watanabe K, Koizumi N, Ozaki O, Futaesaku Y, Hosoya T.
    Endocr J; 1993 Dec 17; 40(6):683-90. PubMed ID: 7951537
    [Abstract] [Full Text] [Related]

  • 19. Immunohistochemical demonstration of epidermal growth factor receptor and ceruloplasmin in thyroid diseases.
    Song B.
    Acta Pathol Jpn; 1991 May 17; 41(5):336-43. PubMed ID: 1867098
    [Abstract] [Full Text] [Related]

  • 20. Differential reactivity of HBME-1 and CD15 antibodies in benign and malignant thyroid tumours. Preferential reactivity with malignant tumours.
    Miettinen M, Kärkkäinen P.
    Virchows Arch; 1996 Nov 17; 429(4-5):213-9. PubMed ID: 8972756
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.